Clinical Trial Update: COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring [Phase 4]

View source ↗

Summary

Phase 4 post-approval registry results for the Corox OTW Steroid LV Lead monitoring in patients with Congestive Heart Failure; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Corox OTW Steroid LV Lead

Snippet

Sponsor: Biotronik, Inc. | Conditions: Congestive Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2012-05-28